首页> 外国专利> Inhalable Pharmaceutical Combination containing a selective agonist of Adenosine A2A Receptors and an anticholinergic tiotropium is not Salt, Pharmaceutical composition containing IT,And its use for preparing Medicine useful in the treatment of obstructive inflammatory disease of the Airways.

Inhalable Pharmaceutical Combination containing a selective agonist of Adenosine A2A Receptors and an anticholinergic tiotropium is not Salt, Pharmaceutical composition containing IT,And its use for preparing Medicine useful in the treatment of obstructive inflammatory disease of the Airways.

机译:含有腺苷A2A受体选择性激动剂和抗胆碱能噻托铵的可吸入药物组合不含盐,含有IT的药物组合物,及其在制备可用于治疗气道阻塞性炎性疾病的药物中的用途。

摘要

The present Invention relates to a combination of a selective A2A adenosine receptor agonist AND anticholinergic agent for simultaneous AdministrationConsecutively or separately via inhalation in the treatment of a disease or other obstructive Airway inflammatory disease.Under the condition that the anticholinergic Agent is not a tiotropium Salt.
机译:本发明涉及选择性A2A腺苷受体激动剂和抗胆碱能药的组合,用于在疾病或其他阻塞性气道炎性疾病的治疗中连续或分开地通过吸入同时给药。在抗胆碱能药不是噻托铵盐的条件下。

著录项

  • 公开/公告号CL2002001112A1

    专利类型

  • 公开/公告日2003-02-27

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号CL2002001112

  • 发明设计人 YEADON MICHAEL.;

    申请日2002-05-24

  • 分类号A61K45/06;A61K9/72;A61P11/00;

  • 国家 CL

  • 入库时间 2022-08-22 00:03:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号